Neogen (NEOG) Cash & Equivalents Growth (3y) (2013 - 2026)
Neogen (NEOG) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.99% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.52% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -0.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 16.75% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.11% |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 33.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 33.55% |
| Nov 30, 2025 | 13.27% |
| Aug 31, 2025 | 9.05% |
| May 31, 2025 | 42.61% |
| Feb 28, 2025 | 43.88% |
| Nov 30, 2024 | 39.99% |
| Aug 31, 2024 | 19.12% |
| May 31, 2024 | 31.17% |
| Feb 29, 2024 | 30.00% |
| Nov 30, 2023 | 21.80% |
| Aug 31, 2023 | 43.16% |
| May 31, 2023 | 35.05% |
| Feb 28, 2023 | 9.76% |
| Nov 30, 2022 | 14.62% |
| Aug 31, 2022 | 23.91% |
| May 31, 2022 | 2.18% |
| Feb 28, 2022 | -22.90% |
| Nov 30, 2021 | -20.46% |
| Aug 31, 2021 | -9.83% |
| May 31, 2021 | -3.09% |